Acquisitions and Divestitures (Details) (USD $)	3 Months Ended		6 Months Ended		6 Months Ended		12 Months Ended		1 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended		12 Months Ended
	Mar. 31, 2013	Jun. 30, 2012 OptiLock Implantable Port [Member]	Jun. 30, 2010 OptiLock Implantable Port [Member]	Jun. 01, 2010 OptiLock Implantable Port [Member]	Jun. 30, 2012 TAArget and UniFit Stent Grafts [Member]	Jun. 30, 2011 TAArget and UniFit Stent Grafts [Member]	Dec. 31, 2011 TAArget and UniFit Stent Grafts [Member]	Dec. 31, 2012 TAArget and UniFit Stent Grafts [Member]	Oct. 31, 2012 Schaublin [Member]	Dec. 31, 2012 Schaublin [Member]	Oct. 31, 2012 Xenosure [Member]	Dec. 31, 2012 Xenosure [Member]	Oct. 31, 2012 Xenosure [Member] Non-compete agreement [Member]	Dec. 31, 2012 TryTech [Member]	Dec. 31, 2012 TryTech [Member]
Acquisition and Divestitures (Textual) [Abstract]
Acquisition date of assets and rights									Jan. 01, 2013		Oct. 31, 2012			Apr. 01, 2013
Payment in exchange of termination									$ 200,000		$ 4,600,000			$ 100,000	$ 100,000
Cash paid for Manufacturing and distribution rights											4,300,000
Goodwill											1,800,000
Maximum goodwill deductable for tax purposes											15 years
Intangible Assets									100,000		2,800,000			100,000	100,000
Weighted-average amortization period for intangibles	6 years 6 months									7 years		12 years	5 years		3 years
Manufacturing and distribution rights											300,000
Transition services as selling expense									100,000
Purchase Price Installments									The purchase price is due in three equal installments with payments made in October 2012 and January 2013 and the final payment due in January 2014.					The purchase price is due in three equal installments with payments made in December 2012 and March 2013 and the final payment due in March 2014.
Agreement date of sale of event				Jun. 01, 2010		Jun. 30, 2011
Sale of product line			200,000			100,000
Payment terms due				30,000
Wrote-off balance under insolvency protection law		52,000
Promissory note received from sale of product line						500,000
Interest on promissory note					7.00%
Estimated fair value of promissory note receivable, other long term assets								200,000
Net charge, recorded in cost of sales							400,000
Receivables on initial promissory note payment					500,000
Outstanding promissory note balance					200,000
Gain on divestiture					$ 300,000